Cambridge Investment Research Advisors’s AIM ImmunoTech Inc. AIM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-203
| Closed | -$9K | – | 3345 |
|
|
2023
Q1 | $9K | Sell |
203
-264
| -57% | -$11.7K | ﹤0.01% | 3136 |
|
|
2022
Q4 | $15K | Sell |
467
-5
| -1% | -$161 | ﹤0.01% | 3067 |
|
|
2022
Q3 | $27K | Buy |
472
+5
| +1% | +$286 | ﹤0.01% | 2989 |
|
|
2022
Q2 | $36K | Hold |
467
| – | – | ﹤0.01% | 2966 |
|
|
2022
Q1 | $49K | Buy |
+467
| New | +$49K | ﹤0.01% | 3078 |
|
|
2021
Q4 | – | Sell |
-467
| Closed | -$94K | – | 3349 |
|
|
2021
Q3 | $94K | Hold |
467
| – | – | ﹤0.01% | 2962 |
|
|
2021
Q2 | $100K | Hold |
467
| – | – | ﹤0.01% | 2973 |
|
|
2021
Q1 | $106K | Buy |
467
+60
| +15% | +$13.6K | ﹤0.01% | 2750 |
|
|
2020
Q4 | $73K | Buy |
407
+65
| +19% | +$11.7K | ﹤0.01% | 2632 |
|
|
2020
Q3 | $73K | Buy |
+342
| New | +$73K | ﹤0.01% | 2424 |
|